文献速递细菌感染、耐药与抗菌药物

老年人常用β-内酰胺类抗生素目标浓度不达标的风险因素:前瞻性队列研究

Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

阿莫西林-克拉维酸组35例中15例达标,哌拉西林-他唑巴坦组39例中33例达标。多变量分析显示合并症负担和eGFR与靶标未达标相关,eGFR 67 mL/min/1.73m2为风险阈值,毒性阈值未超过。

要点

  • 老年患者中阿莫西林-克拉维酸靶标达标率低于哌拉西林-他唑巴坦。
  • 合并症负担和肾功能影响靶标达标,而非年龄。
  • eGFR 67 mL/min/1.73m2与靶标未达标风险增加相关。

核心结论

  • 健康状态和肾功能而非年龄是老年人β-内酰胺类抗生素靶标未达标的主要因素。

主要发现

  • 阿莫西林-克拉维酸组35例中15例达标,哌拉西林-他唑巴坦组39例中33例达标。
  • 多变量logistic回归显示合并症负担(CIRS-G)和eGFR解释23.8%的靶标未达标(P < 0.05)。
  • ROC曲线确定eGFR 67 mL/min/1.73m2为靶标未达标风险增加的阈值。
  • 本研究未超过毒性阈值(阿莫西林总Cmin 80 mg/L,哌拉西林总Cmin 157.2 mg/L)。

关键数值与推荐

  • 靶标达标评估标准为100%fT > MIC。
  • 毒性阈值定义为阿莫西林总Cmin 80 mg/L和哌拉西林总Cmin 157.2 mg/L。

临床怎么用

  • 对老年患者使用阿莫西林-克拉维酸或哌拉西林-他唑巴坦时,应结合合并症负担和肾功能评估靶标达标风险。

局限性

  • 需要进一步研究明确患者间药代动力学变异的预测因素并制定循证给药策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Age-related pathophysiological changes may impact the pharmacokinetics and pharmacodynamics (PK/PD) of ß-lactam antibiotics, potentially resulting in suboptimal concentrations in older adults. This study evaluated PK/PD target attainment with current intravenous amoxicillin-clavulanate and piperacillin-tazobactam dosing regimens in older adults, identified risk factors for target non-attainment, and assessed the prevalence of toxic concentrations. METHODS: This was a prospective, observational PK study in geriatric inpatients (≥75 years) who were treated intravenously with amoxicillin-clavulanate (1 g/0.2 g q6h as a 30-minute infusion) or piperacillin-tazobactam (4 g/0.5 g q6h as a 3-hour infusion). Trough blood samples were collected in steady-state conditions. Target attainment was evaluated against a 100%fT > MIC target. Risk factors for target non-attainment were identified by multivariable logistic regression analysis. Toxicity thresholds were defined as total Cmin concentrations of 80 mg/L for amoxicillin and 157.2 mg/L for piperacillin. RESULTS: Seventy-four patients (median age (IQR): 87 years (83-90)) were included. The PK/PD target was achieved in 15 of 35 and 33 of 39 patients for amoxicillin-clavulanate and piperacillin-tazobactam, respectively. Multivariable logistic regression analysis revealed an effect of comorbidity burden, assessed by the Cumulative Illness Rating Scale-Geriatric (CIRS-G), and estimated glomerular filtration rate that explained 23.8% of target non-attainment (P < 0.05). Receiver operator characteristic curves identified an eGFR of 67 mL/min/1.73m2 as a threshold associated with an increased risk of target non-attainment. Toxicity thresholds were never exceeded in this study. CONCLUSIONS: Health status and renal function, rather than chronological age, play a significant role in target non-attainment among older adults. Further research is required to delineate predictors for interpatient variability in PK and develop evidence-based dosing strategies. TRIAL REGISTRATION: Registration in ClinicalTrials.govTrial registration number: NCT04436991Registration date: 16/06/2020.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. De Clercq A, Desmet T, Boelens J, et al. Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study. J Antimicrob Chemother. 2026. PMID: 41692875. doi:10.1093/jac/dkag048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。